For: |
Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i35/10234.htm |
Number | Citing Articles |
1 |
Chan Hyuk Park. The first-line regimens of Helicobacter pylori eradication in Korea. Hanyang Medical Reviews 2017; 37(1): 2 doi: 10.7599/hmr.2017.37.1.2
|
2 |
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
|
3 |
Huimei Xu, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, Dekui Zhang. Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(6): 775 doi: 10.1097/MEG.0000000000001835
|
4 |
Jae Yong Park, Jae Gyu Kim. NewHelicobacter pyloriEradication Therapies. The Korean Journal of Gastroenterology 2018; 72(5): 237 doi: 10.4166/kjg.2018.72.5.237
|
5 |
Zhiqiang Song, Liya Zhou, Jianzhong Zhang, Lihua He, Peng Bai, Yan Xue. Hybrid Therapy as First‐Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates. Helicobacter 2016; 21(5): 382 doi: 10.1111/hel.12294
|
6 |
Maria José Temido, Dara Mbanze, Nuno Almeida, Bárbara Oliveiros, Elisa Gravito-Soares, Pedro Figueiredo. Is hybrid therapy more efficient in the eradication of Helicobacter pylori infection? A systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials 2023; 22(1) doi: 10.1186/s12941-023-00582-2
|
7 |
Zhi-Qiang Song, Jian Liu, Li-Ya Zhou. Hybrid Therapy Regimen for Helicobacter Pylori Eradication. Chinese Medical Journal 2016; 129(8): 992 doi: 10.4103/0366-6999.179803
|
8 |
Emily C. Tucker, Matthew B. Roberts, David L. Gordon. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2017; 39: 229 doi: 10.1016/bs.seda.2017.07.005
|
9 |
Sumaira Khadim, Iyad Muhammad Naeem, Muhammad Tanveer Alam, Hina Rehman, Sidra Ghayas, Sajjad Haider. The efficacy of moxifloxacin-based triple-therapy in first-line treatment of Helicobacter pylori infection in Pakistan: randomized controlled trials. Archives of Medical Science – Civilization Diseases 2023; 8(1): 31 doi: 10.5114/amscd.2023.131926
|
10 |
Zhi-Qiang Song, Li-Ya Zhou. Hybrid, sequential and concomitant therapies for <i>Helicobacter pylori</i> eradication: A systematic review and meta-analysis. World Journal of Gastroenterology 2016; 22(19): 4766-4775 doi: 10.3748/wjg.v22.i19.4766
|
11 |
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi Journal of Gastroenterology 2023; 29(6): 326 doi: 10.4103/sjg.sjg_288_22
|
12 |
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2018; 71(4): 196 doi: 10.4166/kjg.2018.71.4.196
|
13 |
Ou Jiang, Rong-Xing Zhou, Ke Yang, Chun-Xian Cai, Yu Liu, Nan-Sheng Cheng. Negative short-term impact of intraoperative biliary lavage in patients with hepatolithiasis. World Journal of Gastroenterology 2016; 22(11): 3234-3241 doi: 10.3748/wjg.v22.i11.3234
|
14 |
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016. Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
|